Journal of Cancer Therapy
Vol.9 No.9(2018), Paper ID 87234, 11
pages
DOI:10.4236/jct.2018.99060
Biological Modulation of Parp Inhibition in Triple Negative Breast Cancer, a Combinational Approach Implementing Multitargeted Epigenetic Therapy (Mtet) with Parp Inhibition, in Advanced Breast Cancer: A Case Study
M. Nezami, Steve Hager, Julie Taguchi
Pacific Medical Center of Hope, Fresno, USA
Pacific Medical Center of Hope, Fresno, USA
Pacific Medical Center of Hope, Fresno, USA
Copyright © 2018 M. Nezami, Steve Hager, Julie Taguchi et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Nezami, M. , Hager, S. and Taguchi, J. (2018) Biological Modulation of Parp Inhibition in Triple Negative Breast Cancer, a Combinational Approach Implementing Multitargeted Epigenetic Therapy (Mtet) with Parp Inhibition, in Advanced Breast Cancer: A Case Study.
Journal of Cancer Therapy,
9, 729-739. doi:
10.4236/jct.2018.99060.